ACM Research (ACMR) delivered the kind of top-line quarter growth investors usually reward, yet it still fell short of the bar that mattered most. Non-GAAP earnings of $0.55 per share topped the $0.51 consensus but missed the $0.80 Earnings Whisper number by 31.3%. Revenue rose 36.6% to $367.69 million, edging up from 36% growth in the second quarter and 34% in the first. Earnings grew a slower 19.6% year over year. That gap is the central tension. Demand is accelerating, and management raised full-year guidance for the second straight quarter. But each dollar of new revenue is converting into less profit, and the balance sheet is absorbing the cost of the ramp.

The quality of the quarter deserves scrutiny on two levels. First, there is a large GAAP/non-GAAP split. GAAP diluted EPS was just $0.02, down from $0.52. The main cause was a $39.1 million mark-to-market loss on ACM Shanghai's short-term investments, along with a $7.1 million loss from equity-method investments. Those items are non-operating and excluded from adjusted results, so they explain the headline collapse. They do not explain the more important problem, which is gross margin. Non-GAAP gross margin fell to 41.6%, below the company's 42% to 48% long-term target. It was 46.0% in the second quarter and 46.5% in the first. Management attributed the decline to mix, currency, and inventory provisions, and guided only modest improvement in the fourth quarter. Operating leverage did the heavy lifting instead. Non-GAAP operating expenses fell to 23.6% of revenue from 28.6%, which lifted non-GAAP operating margin to 18.0% from 13.6%.

The call preserved a credible, and arguably strengthening, growth story. Backlog reached $2.5 billion as of late September, up 88% year over year. Year-to-date orders rose 147%, an acceleration from 105% through the first half. Cleaning, ACM's largest category, returned to growth at $210.7 million, up 16.1%, after declines of 14.2% in the second quarter and 5.5% in the first. Management tied the rebound to the single-wafer SPM product cycle and firmed its 2026 SPM shipment target to more than 20 tools, up from 15 to 20. Full-year revenue guidance moved to $1.24 billion to $1.28 billion, or 38% to 42% growth, from $1.125 billion to $1.175 billion. Management also called 2027 a good growth year and argued that China's wafer-fab equipment peak trails the global cycle by a year or two.

Bears still have legitimate ammunition beneath that optimism.

• **Slowing growth in the hottest segments.** ECP growth decelerated to 82.9% from 167.7% in the second quarter and 205% in the first. Advanced packaging growth slowed to 71% from 153%.
• **Product timelines slipped.** Track and PECVD moved from expected production qualification by year-end 2026 to revenue contribution spread through 2027 and 2028. Meaningful furnace revenue is now pushed into 2027.
• **Cash burn widened.** Operating cash use reached $70.4 million, versus $6.4 million in the prior quarter, as a raw-material build lifted inventory to $851 million. Net cash slipped to roughly $0.9 billion from $1.0 billion.
• **Supply and concentration risks persist.** Component constraints still require second and third sourcing, and China concentration remains, with no global customer yet consistently above a 10% revenue threshold.

On the catalyst side, ACM shipped what management calls a world-first 310×310 mm panel-level horizontal plating tool to an Asian customer. It also launched a hot SPM system that recycles 70% of its sulfuric acid. The second Lingang building is coming online and doubles floor space, and fourth-quarter shipments are expected to exceed the third quarter's $343.5 million.

The market setup is more complicated than the guidance raise implies. Shares closed at $44.43 ahead of the report. That is 52.0% below the $92.55 open following the August release, which also marked the inter-earnings high. The stock sat just 2.4% above its inter-earnings low of $43.38, set the day before results, and 35.0% below its 200-day moving average of $68.39. Investor sentiment slipped from essentially neutral (0.0067) to mildly negative (-0.0673), a modest deterioration rather than capitulation. The Earnings Whispers price and AVWAP trend readings remain negative even as momentum reads positive. The stock entered the print deeply out of favor, which partly explains why an elevated whisper coexisted with weak price action.

The bottom line is that ACM's demand picture has rarely looked better: backlog, orders, and guidance all moved decisively higher, and cleaning has turned. But the quarter also showed margin erosion below target, heavier cash consumption, and slipping timelines for newer products, all against a whisper number the company did not come close to reaching. For a stock that has already halved since August, the next leg depends less on order momentum, which looks secure, and more on whether gross margin recovers toward the 42% to 48% range as Lingang capacity and the SPM ramp scale.